Andrea Tan
Stock Analyst at Goldman Sachs
(1.67)
# 3,417
Out of 5,090 analysts
49
Total ratings
44.74%
Success rate
-5.11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Neutral | $27 → $48 | $64.67 | -25.78% | 2 | Nov 20, 2025 | |
| INSM Insmed | Maintains: Buy | $196 → $225 | $205.04 | +9.73% | 13 | Oct 31, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.22 | +260.36% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $81.91 | -37.73% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $8.41 | +221.05% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $6.37 | -5.81% | 5 | Jul 1, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $3.96 | -49.49% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $24.51 | -91.84% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $221.75 | -27.85% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $3.66 | +556.63% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.11 | +261.99% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $591.06 | -36.55% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $80 | $8.31 | +863.28% | 2 | May 24, 2022 |
Arrowhead Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $27 → $48
Current: $64.67
Upside: -25.78%
Insmed
Oct 31, 2025
Maintains: Buy
Price Target: $196 → $225
Current: $205.04
Upside: +9.73%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.22
Upside: +260.36%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $81.91
Upside: -37.73%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $8.41
Upside: +221.05%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $6.37
Upside: -5.81%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $3.96
Upside: -49.49%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $24.51
Upside: -91.84%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $221.75
Upside: -27.85%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $3.66
Upside: +556.63%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.11
Upside: +261.99%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $591.06
Upside: -36.55%
May 24, 2022
Maintains: Neutral
Price Target: $120 → $80
Current: $8.31
Upside: +863.28%